Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy

Abnormal B cell glycosylation in autoimmunity: A new potential treatment strategy

Systemic lupus erythematosus (SLE) and primary Sjögren’s syndrome (pSS) are two autoimmune diseases characterised by the production of pathogenic autoreactive antibodies. Their aetiology is poorly understood. Nevertheless, they have been shown to involve several factors, such as infections and epige...

Full description

Bibliographic Details
Main Authors: Marie Morel, Pierre Pochard, Wiam Echchih, Maryvonne Dueymes, Cristina Bagacean, Sandrine Jousse-Joulin, Valérie Devauchelle-Pensec, Divi Cornec, Christophe Jamin, Jacques-Olivier Pers, Anne Bordron
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-08-01
Series:Frontiers in Immunology
Subjects:
glycosylation
fucosylation
sialylation
N-glycosylation
O-glycosylation
autoimmune diseases
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.975963/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.975963/full

Similar Items